Gérald Marit
Impact in
- Hematology top 0.05%
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 144
- Multiple Myeloma Research and Treatments 58
- Hematopoietic Stem Cell Transplantation 45
- Chronic Myeloid Leukemia Treatments 41
- Acute Myeloid Leukemia Research 36
- Oncology 55
- Cancer Treatment and Pharmacology 24
- Co-authors
- Michel Attal (48 shared papers)Josy Reiffers (70 shared papers)Philippe Moreau (30 shared papers)Denis Caillot (27 shared papers)Thierry Façon (31 shared papers)Jean‐Luc Harousseau (21 shared papers)Hervé Avet‐Loiseau (23 shared papers)Margaret Macro (3 shared papers)
- Journals
- Blood (46 papers)Journal of Clinical Oncology (15 papers)British Journal of Haematology (6 papers)Bone Marrow Transplantation (5 papers)Leukemia (5 papers)
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
Gérald Marit
191 papers receiving 8.7k citations
Gérald Marit's Hit Papers
Peers
Comparison fields: 5 of 123
- Hematology 6.0k
- Genetics 1.9k
- Oncology 2.8k
- Pathology and Forensic Medicine 1.6k
- Rheumatology 667
Countries citing papers authored by Gérald Marit
This map shows the geographic impact of Gérald Marit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gérald Marit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gérald Marit more than expected).
Fields of papers citing papers by Gérald Marit
This network shows the impact of papers produced by Gérald Marit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gérald Marit. The network helps show where Gérald Marit may publish in the future.
Co-authors
The 25 scholars most cited alongside Gérald Marit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 195 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte Hit paper breakdown → | 2010 | 1100 |
| 2 | 2006 | 484 | |
| 3 | 2006 | 471 | |
| 4 | Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis Hit paper breakdown → | 2017 | 409 |
| 5 | 2006 | 401 | |
| 6 | 2010 | 399 | |
| 7 | 2010 | 311 | |
| 8 | 2006 | 253 | |
| 9 | 2009 | 212 | |
| 10 | Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group. | 1995 | 209 |
| 11 | 2003 | 196 | |
| 12 | Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia. | 1986 | 161 |
| 13 | 2002 | 136 | |
| 14 | 1995 | 127 | |
| 15 | 1995 | 125 | |
| 16 | 2009 | 115 | |
| 17 | 2010 | 109 | |
| 18 | 1989 | 98 | |
| 19 | Allogeneic vs autologous stem cell transplantation vs chemotherapy in patients with acute myeloid leukemia in first remission: the BGMT 87 study. | 1996 | 92 |
| 20 | 2008 | 88 |
About Gérald Marit
Gérald Marit is a scholar working on Hematology, Oncology, Genetics, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 195 papers that have together received 9.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (58 papers), Hematopoietic Stem Cell Transplantation (45 papers), Chronic Myeloid Leukemia Treatments (41 papers), Acute Myeloid Leukemia Research (36 papers), Chronic Lymphocytic Leukemia Research (30 papers), Cancer Treatment and Pharmacology (24 papers), Acute Lymphoblastic Leukemia research (20 papers) and Eosinophilic Disorders and Syndromes (18 papers). The work is most often cited by research in Hematology (6.0k citations), Genetics (1.9k citations), Oncology (2.8k citations), Pathology and Forensic Medicine (1.6k citations) and Rheumatology (667 citations). Gérald Marit has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Michel Attal, Josy Reiffers, Philippe Moreau, Denis Caillot, Thierry Façon, Jean‐Luc Harousseau, Hervé Avet‐Loiseau, Margaret Macro, Bertrand Coiffier and Hervé Tilly. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Bone Marrow Transplantation and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.